THE HYDRATEK® PROCESS
HRT®’s advanced HydraTek® process has produced an extensive product offering, including a variety of membrane products, a Cryo-preserved connective tissue matrix and the world’s first ambient temperature, connective tissue matrix allograft. This patent-pending formulation is the only one of its kind in market, and offers physicians and facilities an off-the-shelf, ready-to-use connective tissue matrix for homologous use.
HydraTek® allografts are not compromised by the industry’s standard drying methods, which may lead to protein denaturing and collagen collapse.
HydraTek® flowable grafts are uniquely processed to preserve the natural structure and biological integrity, providing the connective tissue matrix in its natural consistency for improved delivery and performance.
HydraTek® membrane allografts have optimally reduced hydration levels to provide ideal graft handling, strength and performance.